Emo Capital 

$0.026700
6
+$0.01+27.14%Monday 14:24

Statistics

Day High
0.0267
Day Low
0.0267
52W High
13.9
52W Low
0.021
Volume
415
Avg. Volume
18
Mkt Cap
80,233.5
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

Oct 31Expected
Q4 2014
Q4 2015
Q1 2016
Q3 2016
Q4 2016
Q1 2017
Q3 2020
-0
-0
-0
0
Expected EPS
0
Actual EPS
0

Financials

-Profit Margin
Unprofitable
2015
2022
2023
2024
2025
0Revenue
-624,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson operates in the healthcare sector, offering products that could compete with Emo Capital's healthcare investments.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a global pharmaceutical company, competing in the healthcare space where Emo Capital is also investing.
Merck
MRK
Mkt Cap368.89B
Merck is a healthcare company that produces pharmaceuticals and vaccines, directly competing with Emo Capital's healthcare focus.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie is a biopharmaceutical company, its products and research areas may overlap with Emo Capital's healthcare investments.
AMGEN
AMGN
Mkt Cap251.94B
Amgen is a biotech firm, competing in the biopharmaceutical space where Emo Capital could be investing.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb is a pharmaceutical company, which operates in the same healthcare and pharmaceutical sectors as Emo Capital.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences is a biopharmaceutical company, its focus on innovative therapies competes with Emo Capital's investment interests.
Novartis
NVS
Mkt Cap303.67B
Novartis is a global healthcare company, offering products and services that compete with Emo Capital's healthcare investments.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a healthcare company focusing on pharmaceuticals and diagnostics, competing in the same sector as Emo Capital.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific provides analytical instruments and services for the healthcare sector, competing with Emo Capital's investment focus.

About

Emo Capital Corp. operates as a carbon farming company. It is involved in the carbon sequestration business, including carbon sink farms/ranches activities; and development and sale of organic fertilizers, biochar, and carbon credit transactions. The company was incorporated in 2006 and is based in Las Vegas, Nevada.
Show More
CEO
Junhua Adam Guo
Employees
180
Country
United States
ISIN
US29156L2034

Listings

0 Comments

Share your thoughts

FAQs

What is Emo Capital stock price today?▼
The current price of NUVI is $0.03 USD — it has increased by +27.14% in the past 24 hours. Watch Emo Capital stock price performance more closely on the chart.
What is Emo Capital stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Emo Capital stocks are traded under the ticker NUVI.
Is Emo Capital stock price growing?▼
NUVI stock has fallen by -0% compared to the previous week, the month change is a +27.14% rise, over the last year Emo Capital has showed a -99.62% decrease.
What is Emo Capital market cap?▼
Today Emo Capital has the market capitalization of 80,233.5
What were Emo Capital earnings last quarter?▼
NUVI earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Emo Capital revenue for the last year?▼
Emo Capital revenue for the last year amounts to 0 USD.
What is Emo Capital net income for the last year?▼
NUVI net income for the last year is -624,000 USD.
How many employees does Emo Capital have?▼
As of November 2, 2026, the company has 180 employees.
In which sector is Emo Capital located?▼
Emo Capital operates in the Lifestyle & Brands sector.
When did Emo Capital complete a stock split?▼
The last stock split for Emo Capital was on May 5, 2026 with a ratio of 1:1000.
Where is Emo Capital headquartered?▼
Emo Capital is headquartered in Las Vegas, United States.